Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
about
HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptidesPoint mutations define positions in HLA-DR3 molecules that affect antigen presentation.Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.Alloreactivity studied with mutants of HLA-A2.Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansionAutoreactive CD8+ T-cell responses to human myelin protein-derived peptidesRoles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variationHuman HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine developmentProtection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.Secondary anchor substitutions in an HLA-A*0201-restricted T-cell epitope derived from Her-2/neu.Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.Conformational constraints involved in MHC class I restricted antigen presentation.Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapyHuman cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes.Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.The HLA likes and dislikes of allospecific and non-MHC-restricted cytotoxic T lymphocytes.Genetic modulation of antigen presentation by HLA-B27 molecules.HLA-A2 subtypes are functionally distinct in peptide binding and presentation.Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro.
P2860
Q33563433-D423A75F-E363-494E-A871-72C0BBD4CC13Q33645171-D462B6C9-1E73-4615-BCD9-BF38D3E90690Q33681540-B52852A5-2D7B-4CB0-AEE8-C789CFCB82ECQ34313298-AE60C865-C434-41DB-B0EC-E4BAA83E46E9Q34319875-F0F6DC5D-93ED-4835-9EAB-F3F33C361639Q35854416-72924E08-E46C-45FD-A120-D810CA2FE5AEQ35882228-409E49AB-D6F6-4D73-9408-A120F026BCF8Q36067021-BF892B73-BB0B-4B31-BC8B-F2EA971ECA45Q36230273-71B9C24B-0E34-4A2E-86C4-D1CEF2960918Q36231126-95B65BB9-C401-4A51-9C63-2ECE491D5798Q36364315-BC42E3E9-8CE1-4E42-882F-E77C8A2C3372Q36364998-86E9E5AF-DAC5-4E80-ADD2-BC8DD7E9FD6AQ36685753-13303FA9-249B-4E92-8257-4BEC53B79BD9Q36695297-DC05CEC6-D3CE-47F5-B71C-56DB89E4CAC5Q36725920-BAB7C94F-FF61-44CF-BF7A-31411663C75DQ36802213-5FC3D8FA-B9A5-4CAE-B75A-AAE10D6E89C0Q36832847-E0E68D09-6A10-4B5F-95FB-88912F50C763Q37385100-8C7CD1C8-91BA-423D-BD3F-56C7261BDB37Q37435333-0F99268E-9949-4CA0-8670-E90D0EEEE08AQ37482822-FFE0A848-95E4-4C2A-8088-BDAF8FD78B13Q37645886-E0C1FF01-C8BC-4872-9459-3C53A2762506Q39063057-EE746511-906B-46B5-B708-2F45945CEACEQ39548736-37A08E86-1F53-47C7-890A-A2AD4005FD3CQ40965471-F21117B2-69B7-4334-A64E-2AE663843D40Q41338795-E71094CB-5D30-4B63-B38B-072DE2A5BA5DQ41349751-1539482D-D06B-4E1D-9BE4-06513DD2F012Q41642273-933912B6-FB1C-4044-A980-24DF0E9C2DAAQ41815036-27190B2B-CCC8-40C1-994B-E70D7FFE74A3Q44035282-0626E639-97BB-49EF-A079-6A3F23050E92
P2860
Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@ast
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@en
type
label
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@ast
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@en
prefLabel
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@ast
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@en
P2093
P2860
P356
P1476
Mutations in the alpha 2 helix ...... nfluenza virus matrix peptide.
@en
P2093
J E Coligan
V H Engelhard
W E Biddison
P2860
P304
P356
10.1084/JEM.168.2.725
P407
P577
1988-08-01T00:00:00Z